John Sakys - 22 Mar 2023 Form 4 Insider Report for MESA LABORATORIES INC /CO/ (MLAB)

Role
CFO
Signature
John Sakys
Issuer symbol
MLAB
Transactions as of
22 Mar 2023
Transactions value $
-$296,650
Form type
4
Filing time
27 Mar 2023, 09:40:12 UTC
Previous filing
16 Mar 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLAB Common Stock Options Exercise $307K +2.5K +25.78% $122.66 12.2K 22 Mar 2023 Direct
transaction MLAB Common Stock Sale -$429K -2.5K -20.5% $171.62 9.7K 22 Mar 2023 Direct F3
transaction MLAB Common Stock Options Exercise $123K +1K +10.31% $122.66 10.7K 24 Mar 2023 Direct
transaction MLAB Common Stock Sale -$167K -1K -9.35% $167.01 9.7K 24 Mar 2023 Direct F3
transaction MLAB Common Stock Options Exercise $58.5K +1.13K +11.63% $51.85 10.8K 24 Mar 2023 Direct
transaction MLAB Common Stock Sale -$188K -1.13K -10.42% $167.01 9.7K 24 Mar 2023 Direct F3
holding MLAB Common Stock 100 22 Mar 2023 Custodian F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLAB Non Qualified Stock Option Exercise of in-the-money or at-the-money derivative security $0 -2.5K -9.5% $0.00 23.8K 22 Mar 2023 Common Stock 2.5K $122.66 Direct F1
transaction MLAB Non Qualified Stock Option Exercise of in-the-money or at-the-money derivative security $0 -1K -4.2% $0.00 22.8K 24 Mar 2023 Common Stock 1K $122.66 Direct F1
transaction MLAB Non Qualified Stock Option Exercise of in-the-money or at-the-money derivative security $0 -1.13K -4.95% $0.00 21.7K 24 Mar 2023 Common Stock 1.13K $51.85 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/5 exercisable on each anniversary date of the 04/03/17 grant date
F2 1/4 exercisable on each anniversary date of the 04/01/2013 grant date
F3 Sale reported on the Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on June 14, 2022
F4 Consists of 100 shares held by children of which Mr. Sakys is custodian